Pharmaceutics International, Inc. – FDA 483, Nov 14, 2022
Pharmaceutics International Inc. in Cockeysville, MD, a drug product manufacturer, was cited with ten observations during an FDA inspection. The inspection revealed significant deficiencies across multiple areas, including inadequate investigations into out-of-specification results, failures in maintaining aseptic processing environments, insufficient cleaning and maintenance procedures, and a lack of proper validation for analytical methods and manufacturing processes. These issues indicate a systemic breakdown in quality control and adherence to cGMP requirements for sterile drug product manufacturing.
ID · 937931f6-45c4-44ee-8b03-39ff1917c695
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.